Genomics of Drug Sensitivity in Cancer |
AZ628
|
Synonyms |
AZ-628, AZ 628
|
Targets |
BRAF
|
Target pathway |
ERK MAPK signaling
|
PubCHEM ID |
11676786
|
Jsmol |
|
Download molecule |
11676786
|
PUBCHEM IUPAC INCHI |
InChI=1S/C27H25N5O2/c1-17-8-9-21(31-25(33)18-6-5-7-19(12-18)27(2,3)15-28)14-24(17)30-20-10-11-23-22(13-20)26(34)32(4)16-29-23/h5-14,16,30H,1-4H3,(H,31,33)
|
Smiles |
O=C1(N(C=NC4(=C1C=C(NC2(=C(C=CC(=C2)NC(=O)C3(=CC(=CC=C3)C(C#N)(C)C))C))C=C4))C)
|
Cluster number |
62
|
calculated LogS |
-6,584
|
Molecular weight |
451,529
|
calculated LogP |
4,6632
|
H-Acceptors |
7
|
H-Donors |
2
|
Ro5 violations |
0
|
Druglikeness |
-3,6106
|
DrugScore |
4,49509910375331E-02
|
Mutagenic |
high
|
Tumorigenic |
low
|
Reproductive Effective |
low
|
Irritant |
high
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity2 |
1,5545
|
Rat Acute Toxicity |
2,5703
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2+
|
Caco-2 Permeability2 |
1,1583
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor2 |
Inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,5943
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Mitochondria
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-3,8398
|